Jack Derwin

2 weeks ago | capitalbrief.com | Jack Derwin

12:16am on 10 June 2025The news: ASIC says it has agreed on new changes that should cut a week from the IPO approval process for companies looking to float on the ASX. The context: As the corporate regulator reviews public and private markets, ASIC has signalled it will trial changes for the next two years in order to streamline IPOs and reduce the risk of market volatility.

3 weeks ago | capitalbrief.com | Jack Derwin

"Abacus boasts 30% returns with little to no risk, per investor presentations. Average industry returns in the space, however, hover around 12%, per trade publications and multiple experts we interviewed," Morpheus wrote in the report. It claims that Abacus adopted a new valuation methodology just before listing via a special acquisition company (known as a SPAC), which allowed it to "revalue its portfolio periodically and book any increases in value as unrealised gains, or non-cash revenue".

3 weeks ago | capitalbrief.com | Jack Derwin

The last fund manager out of Virgin might be the first one back in as Wilson Asset Management admits its considering participating in the airline's upcoming float. Before the COVID-19 pandemic forced Virgin Australia into administration Wilson Asset Management was one of the last fund managers still on its shareholder register. At the time, gulf carrier Etihad, Singapore Airways and Richard Branson's Virgin Group controlled around 90% of the stock, which traded only in thin volumes on the ASX.

3 weeks ago | capitalbrief.com | Jack Derwin

Six years after it was sensationally targeted by a US hedge fund, the company behind Penfolds and Wolf Blass is once again facing the wrath of short sellers. Six years after it was sensationally targeted by a US hedge fund at one of the world's most closely watched investment conferences, ASX- listed Treasury Wine Estates is once again in the crosshairs of short sellers with a shock leadership change and weak sales for its key brands among the market's biggest concerns.

3 weeks ago | capitalbrief.com | Jack Derwin

Despite half of Australia’s private hospitals running at a loss, the contrarian investor is backing Ramsay Health Care, betting on a turnaround in the troubled sector. The “unsustainable” economics of private healthcare have plunged Healthscope into receivership — but South African investment giant Allan Gray believes there’s still money to be made in the loss-making sector.